oncodailyOpinion

Exploring T-Cell Engager Therapy for Multiple Myeloma – Moffitt Cancer Center

Exploring T-Cell Engager Therapy for Multiple Myeloma - Moffitt Cancer Center / cancer, Cell Coast 2026, Ken Shain, Moffitt ...
BIOENGINEER

Hidden Metabolic Trick Lets Myeloma Cells Steal Fuel to Survive a Key Cancer Drug

New research reveals that resistant myeloma cells import putrescine through the transporter SLC45A4, activating HOXA1-driven ...
Cancer Network

Sequencing Bispecifics and CAR T-Cell Therapy in Myeloma and AL Amyloidosis

A study of teclistamab in combination with daratumumab and lenalidomide (Tec-DR) and talquetamab in combination with ...
oncodaily

Phase 3 Findings Mark Progress in Relapsed or Refractory Multiple Myeloma Treatment – Bristol Myers Squibb

Phase 3 Findings Mark Progress in Relapsed or Refractory Multiple Myeloma Treatment - Bristol Myers Squibb / BMS, Bristol ...

Your Gut Bacteria May Reveal How Cancer Treatment Will Affect You

Certain gut bacteria and their genes were linked to cancer outcomes and chemotherapy side effects. Credit: Shutterstock Gut bacteria may hold clues to cancer survival and chemotherapy side effects ...
BIOENGINEER

Immune Cell Engagers Evolve From Simple Bridges to Smart Biomaterial Platforms

A new review charts how immune cell engagers, from bispecific antibodies and aptamers to surface-engineered cells and ...
Medicina y Salud Pública

Mieloma múltiple: nuevas terapias buscan remisiones más prolongadas

Especialistas en hematología y oncología médica explican los síntomas del mieloma múltiple, las pruebas para diagnosticar y ...

Mercks Milliarden-Blockbuster gerät unter Druck - warum Big Pharma schon die nächste Medikamentengeneration absichert

Anzeige / Werbung Ein Patentstreit in Europa zeigt, wie schwierig es für Pharmakonzerne geworden ist, den Erfolg ihrer ...